Rxivist logo

Patient-derived mutations impact pathogenicity of SARS-CoV-2

By Hangping Yao, Xiangyun Lu, Qiong Chen, Kaijin Xu, Yu Chen, Linfang Cheng, Fumin Liu, Zhigang Wu, Haibo Wu, Changzhong Jin, Min Zheng, Nanping Wu, Chao Jiang, Lanjuan Li

Posted 19 Apr 2020
medRxiv DOI: 10.1101/2020.04.14.20060160

The sudden outbreak of the severe acute respiratory syndrome-coronavirus (SARS-CoV-2) has spread globally with more than 1,300,000 patients diagnosed and a death toll of 70,000. Current genomic survey data suggest that single nucleotide variants (SNVs) are abundant. However, no mutation has been directly linked with functional changes in viral pathogenicity. Here we report functional characterizations of 11 patient-derived viral isolates, all of which have at least one mutation. Importantly, these viral isolates show significant variation in cytopathic effects and viral load, up to 270-fold differences, when infecting Vero-E6 cells. We observed intrapersonal variation and 6 different mutations in the spike glycoprotein (S protein), including 2 different SNVs that led to the same missense mutation. Therefore, we provide direct evidence that the SARS-CoV-2 has acquired mutations capable of substantially changing its pathogenicity.

Download data

  • Downloaded 74,159 times
  • Download rankings, all-time:
    • Site-wide: 90
    • In infectious diseases: 33
  • Year to date:
    • Site-wide: 1,342
  • Since beginning of last month:
    • Site-wide: 2,439

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide